Lotensin Hct



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 60.0%
Depression 7.5%
Hypersensitivity 5.0%
Alcoholism 2.5%
Anxiety 2.5%
Arrhythmia 2.5%
Atrial Fibrillation 2.5%
Gastritis 2.5%
Headache 2.5%
Hyperuricaemia 2.5%
Mental Disorder 2.5%
Protein Urine Present 2.5%
Sleep Disorder 2.5%
Vertigo 2.5%
Ventricular Septal Defect 14.8%
Hypertension 7.4%
Swollen Tongue 7.4%
Vagus Nerve Disorder 7.4%
Weight Increased 7.4%
Drug Exposure During Pregnancy 3.7%
Gestational Diabetes 3.7%
Maternal Exposure During Pregnancy 3.7%
Medication Error 3.7%
Pain In Extremity 3.7%
Papilloedema 3.7%
Premature Baby 3.7%
Prostatic Calcification 3.7%
Renal Disorder 3.7%
Restlessness 3.7%
Scotoma 3.7%
Skin Warm 3.7%
Syncope 3.7%
Urinary Incontinence 3.7%
Vomiting 3.7%
Secondary
Hypertension 53.8%
Diabetes Mellitus 11.5%
Coronary Artery Disease 7.7%
Lipids Increased 7.7%
Pain 7.7%
Atrial Fibrillation 3.8%
Hypersensitivity 3.8%
Menopausal Symptoms 3.8%
Renal Failure 16.7%
Vagus Nerve Disorder 16.7%
Weight Increased 16.7%
Blood Pressure Inadequately Controlled 8.3%
Dizziness 8.3%
Drug Exposure During Pregnancy 8.3%
Drug Ineffective 8.3%
Premature Baby 8.3%
Vaginal Haemorrhage 8.3%
Concomitant
Hypertension 16.0%
Product Used For Unknown Indication 14.6%
Diabetes Mellitus 8.5%
Osteoporosis 6.7%
Pain 5.8%
Type 2 Diabetes Mellitus 5.5%
Sleep Disorder 4.4%
Vitamin Supplementation 4.1%
Blood Cholesterol Increased 3.8%
Adenocarcinoma 3.5%
Osteopenia 3.5%
Blood Cholesterol 3.2%
Blood Pressure 3.2%
Cough 3.2%
Constipation 2.6%
Rheumatoid Arthritis 2.6%
Anxiety 2.3%
Menopause 2.3%
Depression 2.0%
Dyslipidaemia 2.0%
Urinary Tract Infection 16.4%
Weight Decreased 13.4%
Vomiting 9.0%
Tracheal Fistula 6.0%
Pain In Extremity 4.5%
Renal Failure 4.5%
Tremor 4.5%
Tricuspid Valve Incompetence 4.5%
Vision Blurred 4.5%
Alopecia 3.0%
Arthropathy 3.0%
Bladder Transitional Cell Carcinoma 3.0%
Fatigue 3.0%
Flushing 3.0%
Loss Of Consciousness 3.0%
Malaise 3.0%
Pancreatitis 3.0%
Peripheral Vascular Disorder 3.0%
Scotoma 3.0%
Swelling Face 3.0%